http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100834718-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 |
| filingDate | 2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100834718-B1 |
| titleOfInvention | Bone Formation Promoting Cell Composition Promoting Bone Regeneration and Manufacturing Method Thereof |
| abstract | The present invention relates to a bone formation promoting cell composition for promoting bone regeneration extensively partially or systemically by surface treatment of hyaluronic acid using a hyaluronic acid and then injected into the circulation.n n n The present invention comprises the steps of (A) separating the bone-forming autologous cells from the bone marrow of the animal; (B) proliferating and culturing the isolated cells in Dulbecco's Modified Eagle's Medium (DMEM) or Minimum Essential Medium, Alpha Modification (α-MEM) culture to prepare a cell suspension having bone formation ability; And (c) mixing the surface of the cell by mixing a low molecular weight hyaluronic acid of less than 1 million MW (molecular weight) as a biological substrate component to the cell suspension having bone formation ability.n n n The present invention configured as described above is a surface treatment using a hyaluronic acid to the bone-forming cells and then injected into the circulatory system to be able to promote bone regeneration extensively in part or systemic, in particular through the blood flow to the bone formation agent When injected, the bone formation cells are evenly delivered to the site where bone formation is required without destroying the remaining bone tissue structure. Thus, it is possible to treat various diseases including osteoporosis requiring extensive bone regeneration, thereby greatly improving the quality and reliability of the product. It is to improve consumers to plant a good image.n n n n Bone forming cells, osteoporosis, hyaluronic acid, cell coating. |
| priorityDate | 2006-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.